Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rang in Aktien #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Aktienkurs
$42.98
Zuletzt synchronisiert: 2024-06-21
Marktkapitalisierung
$1.62B
Veränderung (1 Tag)
0.01%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel Taro Pharmaceutical Industries Ltd. (TARO)

Kategorie

Anzahl der ausstehenden Aktien von Taro Pharmaceutical Industries Ltd. (TARO)
Anzahl der ausstehenden Aktien zum March 2024: 37.58M
Laut den neuesten Finanzberichten und dem Aktienkurs von Taro Pharmaceutical Industries Ltd. beträgt die aktuelle Anzahl der ausstehenden Aktien 37.58M. Am Ende von March 2023 hatte das Unternehmen 37.58M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Taro Pharmaceutical Industries Ltd. (TARO) von 1999 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 37.58M 0.00%
2024 37.58M 0.00%
2023 37.58M -0.15%
2022 37.64M -1.49%
2021 38.21M -0.65%
2020 38.46M -1.36%
2019 38.99M -2.90%
2018 40.16M -2.77%
2017 41.30M -3.58%
2016 42.83M 0.00%
2015 42.83M -3.26%
2014 44.28M -0.90%
2013 44.68M 0.00%
2012 44.68M 10.94%
2010 40.27M 2.65%
2009 39.23M 0.08%
2008 39.20M 12.89%
2007 34.73M 18.33%
2006 29.35M 0.33%
2005 29.25M 0.36%
2004 29.14M 1.03%
2003 28.85M 0.35%
2002 28.75M 22.75%
2001 23.42M 9.33%
2000 21.42M 6.30%
1999 20.15M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern